Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)
| العنوان: | Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study) |
|---|---|
| المؤلفون: | Mónica Carreira, Stella González Romero, Gabriel Olveira, Francisca Linares, María Rosario Vallejo Mora, María Teresa Anarte |
| المصدر: | Diabetes Technology & Therapeutics |
| بيانات النشر: | Mary Ann Liebert Inc, 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Bolus calculator, Adult, Blood Glucose, Male, medicine.medical_specialty, Adolescent, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Hypoglycemia, law.invention, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Bolus (medicine), law, Diabetes mellitus, medicine, Psychology, Humans, Hypoglycemic Agents, Insulin, 030212 general & internal medicine, Glycated Hemoglobin, Type 1 diabetes, business.industry, Multiple daily injections of insulin, Original Articles, Fear, Middle Aged, medicine.disease, Surgery, Clinical trial, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Calculator, Anesthesia, Metabolic control analysis, Female, business, Postprandial Hypoglycemia |
| الوصف: | Background: In a previous study we demonstrated improvement in metabolic control and reduction in hypoglycemia in people with type 1 diabetes on multiple daily injections, after having used a bolus calculator for 4 months. Objective: To demonstrate whether (1) extending its use (2) or introducing it in the control group, previously subjected to treatment intensification, could further improve metabolic control and related psychological issues. Methods: After the previous clinical trial, in which the subjects were randomized either to treatment with the calculator or to control group for 4 months, both groups used the calculator during an additional 4-month period. Results: In the previous control group, after using the device, HbA1c did not improve (7.86% ± 0.87% vs. 8.01% ± 0.93%, P 0.215), although a significant decrease in postprandial hypoglycemia was observed (2.3 ± 2 vs. 1.1 ± 1.2/2 weeks, P 0.002). In the group in which the treatment was extended from 4 to 8 months, HbA1c did not improve either (7.61 ± 0.58 vs. 7.73 ± 0.65, P 0.209); however this group had a greater perceived treatment satisfaction (12.03 ± 4.26 vs. 13.71 ± 3.75, P 0.007) and a significant decrease in fear of hypoglycemia (28.24 ± 8.18 basal vs. 25.66 ± 8.02 at 8 months, P 0.026). Conclusions: The extension in the use of the calculator or its introduction in a previously intensified control group did not improve metabolic control, although it did confirm a decrease in hypoglycemic episodes in the short term, while the extension of its use to 8 months was associated with a reduction in fear of hypoglycemia and greater treatment satisfaction. |
| وصف الملف: | application/pdf |
| تدمد: | 1557-8593 1520-9156 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c89ad1b759a0a754c8462ced199ae9eTest https://doi.org/10.1089/dia.2017.0019Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....7c89ad1b759a0a754c8462ced199ae9e |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15578593 15209156 |
|---|